Unable to get its cosmetics plant project financed, Global Bioenergies is now focusing all its efforts on SAF opportunities

PRESS RELEASE Unable to get its cosmetics plant project financed, Global Bioenergies is now focusing all its efforts on SAF opportunities Evry, 17 October 2024 – 07:30 a.m.: After several months of efforts, the Company has been unable to find investors for its 2,500-ton plant dedicated to the cosmetics market, in a highly unfavorable context […]

Press Release: Sanofi and Orano join forces to develop next-generation radioligand medicines

Sanofi and Orano join forces to develop next-generation radioligand medicines Paris, October 17, 2024. Sanofi and Orano Med, a subsidiary of the Orano Group and a pioneer in the development of targeted alphatherapies in oncology, have entered into an agreement to combine their expertise in the fight against rare cancers and further accelerate the development

Nicox Provides Third Quarter 2024 update and First Half 2024 Financial Results

Press Release Nicox Provides Third Quarter 2024 update and First Half 2024 Financial Results Topline results from the NCX 470 (bimatoprost grenod) Phase 3 Denali clinical trial expected in Q3 2025 Cash of EUR19.7 million on September 30, 2024, including the estimated net proceeds of the VYZULTA royalty sale and equity investment announced on October

Viridien Announces its Q3 Financial Results on Thursday 31st October 2024, after Market Close

Paris, France – October 17th, 2024 Viridien, formerly CGG, will announce its third quarter 2024 financial results on Thursday, October 31st, after market close. The press release and the presentation will be made available on our website www.viridiengroup.com at 5:45 pm (CET) An English language analysts conference call is scheduled the same day at 6.00

Hansa Biopharma Reports Third Quarter and Interim January – September 2024 Financial Results

Q3 2024 marks highest ever in-market quarterly sales performance and fourth consecutive quarter of strong sales performance Hansa Biopharma today announced its interim report for January-September and third quarter 2024 financial results. Søren Tulstrup, President and CEO, Hansa Biopharma said, “The third quarter of 2024 marks the highest ever IDEFIRIX® sales performance to date, resulting

Euroclear invests in Singapore-based digital market infrastructure Marketnode

— Investment supportsEuroclear’s growth strategy in the Asia-Pacific region — Euroclear joins Marketnode’s major shareholders Singapore Exchange (SGX Group), Temasek and HSBC Euroclear today announced it has acquired a strategic stake in Marketnode, a Singapore-based digital market infrastructure operator. Financial terms of the transaction will not be disclosed. https://mma.prnewswire.com/media/2064818/4819610/Euroclear_logo.jpg Founded by SGX Group and Temasek

DUBAI WATCH WEEK’S HOROLOGY FORUM SET TO PREMIERE IN HONG KONG, CELEBRATING THE ESSENCE OF HOROLOGY AT ITS FINEST FROM 22ND -24TH OCTOBER

Dubai Watch Week is set to host the 10th edition of the globally renowned Horology Forum, which will be making its debut in the bustling city of Hong Kong. An integral programme within the Dubai Watch Week platform, Horology Forum hosts invaluable conversations and intellectual engagements within horology and other industries alike, led by experts

Euroclear invests in Singapore-based digital market infrastructure Marketnode

— Investment supportsEuroclear’s growth strategy in the Asia-Pacific region — Euroclear joins Marketnode’s major shareholders Singapore Exchange (SGX Group), Temasek and HSBC Euroclear today announced it has acquired a strategic stake in Marketnode, a Singapore-based digital market infrastructure operator. Financial terms of the transaction will not be disclosed. https://mma.prnewswire.com/media/2064818/4819610/Euroclear_logo.jpg Founded by SGX Group and Temasek

Nokia Corporation Interim Report for Q3 2024

Nokia CorporationInterim Report17 October 2024 at 08:00 EEST Nokia Corporation Interim Report for Q3 2024 Strong gross margin improvement amidst ongoing market weakness Q3 net sales declined 7% y-o-y in constant currency (-8% reported) as growth in Network Infrastructure and Nokia Technologies was offset by decline in Mobile Networks primarily in India and a divestment

Thomas Jefferson University Announces Tender Offer for Outstanding Debt Securities

Thomas Jefferson University (“TJU”) today announced that it has commenced a tender offer to purchase for cash the debt securities issued by TJU listed in the table below (the “Securities”). Up to $108,000,000 Aggregate Tender Cap for the Securities of Thomas Jefferson University Listed Below in the Acceptance Priority Levels CUSIP No. Principal Amount Outstanding

Scroll to Top